CLINICAL_TRIALS
research
· 2025-11-21
Clinical Trial Update: Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients [NA]
Summary
A clinical trial update describing Hyperthermic Intravesical Chemotherapy (HIVEC) for high-grade non-muscle invasive bladder cancer that is non-responsive to BC…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AC.TA. S.r.l. | Conditions: Non Muscle Invasive Bladder Cancer, Bladder Cancer | NA | Status: NOT_YET_RECRUITING